Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 3 (2007), Issue 9 (September)

1. Role of nanotechnology in pharmaceutical product development.
   J Pharm Sci, 96(10): 2547-65. [Abstract] [Full-text]
2. Quantitative structure-permeation relationship for iontophoretic transport across the skin.
   J Control Release, 122(2): 165-72. [Abstract] [Full-text]
3. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
   Int J Antimicrob Agents, 30(4): 325-9. [Abstract] [Full-text]
4. Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals.
   Mutat Res, 623(1): 98-108. [Abstract] [Full-text]
5. Molecular medicine: how, what, and when?
   Clin Pharmacol Ther, 82(4): 376-8. [Abstract] [Full-text]
6. Translation of pharmacogenetics into clinically relevant testing modalities.
   Clin Pharmacol Ther, 82(4): 373-6. [Abstract] [Full-text]
7. Beyond genomics.
   Clin Pharmacol Ther, 82(4): 366-70. [Abstract] [Full-text]
8. Drug discovery and development in the age of molecular medicine.
   Clin Pharmacol Ther, 82(4): 363-6. [Abstract] [Full-text]
9. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
   J Med Chem, 50(19): 4606-15. [Abstract] [Full-text]
10. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.
    J Med Chem, 50(19): 4642-7. [Abstract] [Full-text]
11. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Clin Pharmacol Ther, 82(4): 472-5. [Abstract] [Full-text]
12. The emerging role of pharmacogenomics in biologics.
    Clin Pharmacol Ther, 82(4): 466-71. [Abstract] [Full-text]
13. Finding a liability-free space in which personalized medicine can bloom.
    Clin Pharmacol Ther, 82(4): 461-5. [Abstract] [Full-text]
14. Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methods.
    J Med Chem, 50(19): 4665-8. [Abstract] [Full-text]
15. Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges.
    Clin Pharmacol Ther, 82(4): 427-34. [Abstract] [Full-text]
16. Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of human erythropoietin.
    Endocrinology, 148(10): 5081-7. [Abstract] [Full-text]
17. Challenges in the development of prescription opioid abuse-deterrent formulations.
    Clin J Pain, 23(8): 648-60. [Abstract] [Full-text]
18. Structure-guided drug design: conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypes.
    Biochem Pharmacol, 74(8): 1164-71. [Abstract] [Full-text]
19. Neuronal nicotinic receptors: a perspective on two decades of drug discovery research.
    Biochem Pharmacol, 74(8): 1092-101. [Abstract] [Full-text]
20. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
    Proc Natl Acad Sci U S A, 104(39): 15490-5. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.